General Information

Intended Audience

This conference is intended for R.Ph.s practicing in the acute care and ambulatory care practice settings; R.Ph.s responsible for the clinical and administrative management of patients diagnosed with colon cancer.

Web cast Agenda

The web cast has 2 separate lectures to view:

Clinical Update and Pharmacogenomics of Colon Cancer
Economics of Colon Cancer Treatement

Instructions

To receive continuing education credit, you must view the web cast, take a post-test and complete a program evaluation. Upon successful completion, you will have access to print your statement of credit from the website.

1. Register online for Clinical, Pharmacogenomic and Economic Update on Colon Cancer. You will need to log-in with your username and password. If this is your first time taking a course through Extension Services in Pharmacy you will need to create a new account.
2. Once registered, the course page will have links to the two lectures. Listen to the lectures and view the corresponding slides. There will also be printable versions of the slides available for printing.
3. After listening to the lectures, select Post-Test for Clinical, Pharmacogenomic and Economic Update on Colon Cancer. Complete on-line and submit answers. You must achieve a minimum score of 70% correct. In the event your score is below 70%, you will be provided with an option to “retake” the post-test by changing the previously recorded response(s).
4. Upon successful completion of the Post-Test, select “Evaluation of Clinical, Pharmacogenomic and Economic Update on Colon Cancer." Complete and submit evaluation responses.
5. You will then be able to click on Clinical, Pharmacogenomic and Economic Update on Colon Cance Certificate, listed under "Statement of Credit", to view and print statement of credit.
6. For assistance, please contact Extension Services in Pharmacy by email or 608-890-03120.

MENU

Faculty

Jill M. Kolesar, Pharm.D., BCPS, FCCP received a Doctor of Pharmacy and completed a specialty practice residency in oncology/hematology and a 2-year fellowship in molecular oncology pharmacotherapy at the University of Texas Health Science Center in San Antonio, Texas. Jill is currently an Associate Professor of Pharmacy at the University of Wisconsin School of Pharmacy and the Director of the Analytical Laboratory and Pharmacogenetics Facility at the University of Wisconsin Comprehensive Cancer Center. Dr. Kolesar practices in the Hematology and Oncology Clinics at the William S. Middleton VA Hospital in Madison, Wisconsin, managing the pharmacotherapy of ambulatory patients and her research in pharmacogenomics includes the use of molecular markers to predict response and monitor efficacy of cancer chemotherapy, population genotyping for cancer susceptibility, and the regulation of gene expression of the two electron reductases. She has authored more than 100 abstracts, research articles, and book chapters, and as a principal investigator, she has received more than $750,000 in research funding from the NCI, ACS and other sources. In addition, she holds 2 US patents for novel assay methodologies for gene expression and mutation analysis. She has received several research awards from local, national and international pharmacy organizations and a Merit Award from the American Society of Clinical Oncology. She received the Innovations in Teaching Award from the American Association of Colleges of Pharmacy in 2001. She serves on the editorial boards of Lexi-Comp’s Pharmacogenomics Handbook, ACCP’s Pharmacogenomics: Applications to Patient Care, the Journal of Oncology Pharmacy Practice, and the textbook, Pharmacotherapy: Principles and Practice. She has served ACCP on the Board of Regents and as Chair of Hematology Oncology PRN and the National Cancer Institute Central IRB, as the Chair of the Adverse Events Subcommittee.

Lee C. Vermeulen, Jr., R.Ph., M.S, FCCP is the Director of the Center for Drug Policy in the Department of Pharmacy at the University of Wisconsin Hospital and Clinics, and Clinical Associate Professor at the UW-Madison School of Pharmacy. He received a Bachelors Degree in pharmacy from the University of Buffalo, and a Masters in pharmacy administration from the University of Wisconsin-Madison. He completed residency training in pharmacy practice and pharmacy administration at the University of Wisconsin Hospital and Clinics, and served a fellowship in medical technology assessment at the University Healthsystem Consortium. In his role at the UW Hospital and Clinics, he leads a large team of pharmacists responsible for drug policy analysis and drug formulary management for both his academic medical center and for Unity Health Insurance, an 85,000 member managed care organization owned by the UW Health system. Mr. Vermeulen also conducts health services research with a focus on studies that measure the value of both medication therapy and clinical pharmacy services. He is involved in the evaluation of technology development and diffusion, particularly in the pharmaceutical market, and he publishes annual forecasts of the medication development pipeline and forecasts of the rising cost of medications. His previous scholarly work has focused on measuring the impact of various health-system medication use policies and programs. Mr. Vermeulen is active in several professional organizations, including the Pharmacy Society of Wisconsin, ASHP, ACCP, and currently serves as the Assistant Secretary of the Hospital Pharmacy Section of the International Pharmacy Federation (FIP).